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Background: To explore the likely influence and impact of shared decision-making on medical malpractice litigation and
patients’ intentions to initiate litigation.
Methods: We included all observational, interventional and qualitative studies published in all languages, which assessed
the effect or likely influence of shared decision-making or shared decision-making interventions on medical malpractice
litigation or on patients’ intentions to litigate. The following databases were searched from inception until January 2014:
CINAHL, Cochrane Register of Controlled Trials, Cochrane Database of Systematic Reviews, EMBASE, HMIC, Lexis library,
MEDLINE, NHS Economic Evaluation Database, Open SIGLE, PsycINFO and Web of Knowledge. We also hand
searched reference lists of included studies and contacted experts in the field. Downs & Black quality assessment
checklist, the Critical Appraisal Skill Programme qualitative tool, and the Critical Appraisal Guidelines for single
case study research were used to assess the quality of included studies.
Results: 6562 records were screened and 19 articles were retrieved for full-text review. Five studies wee included
in the review. Due to the number and heterogeneity of included studies, we conducted a narrative synthesis adapted
from the ESRC guidance for narrative synthesis. Four themes emerged. The analysis confirms the absence of empirical
data necessary to determine whether or not shared decision-making promoted in the clinical encounter can
reduce litigation. Three out of five included studies provide retrospective and simulated data suggesting that
ignoring or failing to diagnose patient preferences, particularly when no effort has been made to inform and
support understanding of possible harms and benefits, puts clinicians at a higher risk of litigation. Simulated
scenarios suggest that documenting the use of decision support interventions in patients’ notes could offer some
level of medico-legal protection. Our analysis also indicated that a sizeable proportion of clinicians prefer ordering more
tests and procedures, irrespective of patient informed preferences, as protection against litigation.
Conclusions: Given the lack of empirical data, there is insufficient evidence to determine whether or not shared
decision-making and the use of decision support interventions can reduce medical malpractice litigation. Further
investigation is required.
Trial registration: This review was registered on PROSPERO. Registration number: CRD42012002367.
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While policies are evolving to reflect a progressive shift
in medical practice towards patient-centered care [1-4],
the approach known as shared decision-making has yet
to become incorporated as usual care. King and Moulton
have argued that current standards of informed consent
are unfit for the rapidly evolving medical landscape [5],
where approximately 47% of all medical treatments are
“preference-sensitive” [6]. They advocate that adopting
shared decision-making would lead to important and
necessary reforms in the area of informed consent. In
situations of clinical equipoise, also known as preference-
sensitive decisions, it is widely argued that individual pa-
tient preferences [7] should become the guiding principle
for patients making informed decisions together with their
healthcare providers [8].
Poor communication and lack of information are the
most commonly reported sources of patient dissatisfaction
in healthcare [9,10]. Extensive evidence has confirmed that
communication failures are strongly correlated with med-
ical malpractice litigation [11-15]. Physicians’ inability to
clearly communicate with their patients, to disclose risks
and benefits, and to answer their questions, are common
predictors of medical malpractice claims [1,16,17]. Levinson
analyzed communication behaviors between physicians
who had never experienced malpractice litigation and those
who had previously been sued, and found that the latter
tended to demonstrate poorer communication skills. They
were also less likely to form helpful interactions with
patients: “relationships matter to both patients and
physicians and the relationship itself may be the most
powerful antidote to the malpractice crisis that medicine
can provide” [11,17].
There is considerable hope that sharing decisions with
patients using good communication skills and tools that
improve provider-patient communication and under-
standing of the harm versus benefit trade-offs would
lead to lower litigation levels. However, there is yet no
evidence to confirm that it is indeed the case. Shared
decision-making is defined as involving a patient and
health care provider who work together to deliberate
about the harms and benefits of two or more reasonable
options, in order to choose a course of care that is
ideally aligned with the patient’s preferences [18]. Evi-
dence from controlled contexts suggest that shared
decision-making can improve patient outcomes by in-
creasing knowledge, realistic expectations, participation
in decision-making and reducing post-intervention in-
decision compared to usual practice [19]. There is un-
certainty around its impact on cost and litigation rates
[19,20]. Notwithstanding, researchers, policy makers and
key stakeholders in this area often speculate that shared
decision-making, facilitated by the use of decision sup-
port interventions, may reduce litigation rates or limitphysicians’ liability in lawsuits [5,21]. In the United
States, things are evolving rapidly. Several states (Maine,
Vermont, Massachusetts, Minnesota, and Washington)
have adopted legislation to promote Shared Decision-
Making (SDM) [1]. However there is no widespread
adoption of SDM as an alternative to traditional means
of obtaining informed consent and no evidence that
SDM may lead to reduced litigation.
It is thus important to examine whether SDM (patient
participation in decision-making and/or elicitation of pa-
tient preferences) and related interventions might reduce
preventable litigation. Our aim is to explore the likely
impact and influence of shared decision-making and
shared decision-making interventions on medical mal-
practice litigation, and patients’ intentions to initiate
litigation.Methods
The systematic review protocol was registered on PROS-
PERO in May 2012 (Registration number CRD420120
02367). We planned and reported the review in accord-
ance with the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) [22] (see protocol
in Additional file 1 and PRISMA checklist in Additional
file 2).Study selection and inclusion criteria
After removing duplicates and irrelevant studies, three
researchers independently screened the title and abstract
of retrieved records. Disagreements were resolved by
discussion. Two researchers independently screened full-
text articles.
We included all observational, interventional and quali-
tative studies published in all languages, which assessed
the effect or likely influence of shared decision-making
(patient participation in decision-making and/or elicitation
of patient preferences) or shared decision-making inter-
ventions on medical malpractice litigation or on patients’
intentions to litigate. Shared decision-making interventions
were defined as the use of tools or strategies designed to
engage patients in medical decision-making and/or facili-
tate shared decision-making and patient activation the
medical encounter, by providing information about the op-
tions and associated outcomes and implicit methods to
clarify values [19]. Interventions designed to promote in-
formed consent or communication were included in the re-
view if the standard process of consenting and informing
patients was complemented by an effort to involve patients
in the decision-making process and elicit their preferences.
We included all study outcomes related to litigations.
We excluded studies that exclusively examined the im-
pact of communication skills, provision of information or
informed consent on medical malpractice litigation, without
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decision-making and/or elicitation of patient preferences.
Search methods
The search strategy was developed with an Information
Specialist and piloted in OVID MEDLINE (see Additional
file 3). We combined keywords and Medical Subject Head-
ing terms for shared decision-making, decision-making, pa-
tient participation, doctor-patient relationship, informed
decision, decision support, decision support techniques, liti-
gation, medical malpractice, liability, medical negligence
claim and legal proceedings (see full list in Additional file
3). The following electronic databases were searched from
inception until January 2014: CINAHL, Cochrane Central
Register of Controlled Trials, Cochrane Database of
Systematic Reviews, EMBASE, HMIC, Lexis Library,
MEDLINE, MEDLINE In-Process and Other Non-Indexed
Citations, NHSEED, Open SIGLE, PsycINFO and Web of
Knowledge. Conference proceedings and the reference list
of all primary and review articles were hand searched. A
“cited by” search and “related articles” search were also
performed on PubMed. We used social media lists to con-
tact 378 individuals registered as having special interests in
this area.
Quality assessment and data extraction
Independent dual data extraction was performed using a
piloted pre-designed form. We extracted information about
the 1) the author(s)/publication year, 2) type of publication
3) country, 4) source of funding, 5) study purpose, 6) dur-
ation, 7) study type, 8) methodological approach, 9) recruit-
ment procedure, 10) theoretical framework, 11) participant
characteristics, 12) sample size, 13) setting, 13) type of
intervention (if applicable), 14) duration of intervention,
15) follow-up, 16) control condition, 17) methods of ana-
lysis, 18) number of participants enrolled, included in ana-
lysis, withdrawn and lost to follow-up for both intervention
and control groups, 19) outcome measures (type of medical
malpractice litigation, outcome of the litigation and factors
affecting the outcome, duration of the litigation, litigation
cost, accessibility, usability of intervention).
We used Downs & Black quality assessment checklist
[23] to assess the quality of observational studies. This
checklist was selected for its psychometric properties and
relevance for assessing non-randomized studies [23]. Quali-
tative studies were assessed using a qualitative appraisal
tool developed by the Critical Appraisal Skill Programme
(CASP)[24]. The quality of case studies was independently
assessed by two researchers, using the critical appraisal
guidelines for single case study research [25].
Evidence synthesis
The Economic and Social Research Council (ESRC)
guidance for narrative synthesis [26], which we followedand adapted, stipulates that a narrative analysis should
be driven by a theoretical model, should include a pre-
liminary synthesis of included study findings, an assess-
ment of the principal trends and relationships in the
data, and an examination of the robustness of the find-
ings. For this review, we hypothesized that taking active
steps to involve patients in sharing preference-sensitive
decisions about their care, such as eliciting individual
preferences, would reduce the risk of medical malprac-
tice litigation, actual malpractice suits and related costs
(see Figure 1). The ESRC guidance recommends that be-
fore undertaking a review, the authors first develop a
‘theory of change’, that describes how the intervention or
concept works. The theory of change outlined in Figure 1
was developed prior to data extraction to inform deci-
sions about the review questions and the type of studies
to include. A preliminary synthesis was subsequently
undertaken using the extracted data organized in a tabu-
lar form. The study quality was examined and the rela-
tionships and patterns in the data were thematically
analyzed and synthesized.
Results
8803 citations were identified from database search and
40 from other sources. After duplicates and irrelevant
hits had been removed, 6562 records were screened and
19 articles were retrieved for full-text review. Fourteen
studies were excluded upon full-text review for the fol-
lowing reasons: 1) the studies did not evaluate the im-
pact of shared decision-making on litigation or intention
to litigate (n = 9); 2) the study did not include any data
(e.g. editorial/opinion article) (n = 5). Five articles met
our inclusion criteria [27-31] (see Figure 2). We note
that 14 editorials and opinion articles, published be-
tween 1980 and 2009, hypothesized about the potential
for shared decision-making to reduce medical malprac-
tice claims. They were not based on empirical data, and
were therefore excluded. A much greater number of ci-
tations explored the relationship between poor commu-
nication or inadequate informed consent and medical
malpractice litigation but failed to consider patient in-
volvement in decision-making, and were thus excluded.
The five included studies report data collected in three
countries (United States, United Kingdom and Korea), and
were published between 1994 and 2008. They encompass
the following study designs: Four qualitative studies (in-
cluding two case studies), and one quasi-experimental de-
sign. The sample size was generally small, ranging from 1
(case studies) to 886 participants. Two studies involved an
intervention designed to enhance informed patient choice
and shared decision-making: a video-based decision aid for
PSA testing [28] and a series of evidence-based leaflets for
maternity care [30] (see Table 1). Four studies were con-
ducted with patients from primary and secondary care
Likely reduced medical malpractice 
litigation and associated costs
Increased risk of medical malpractice
litigation and associated costs
Two or more reasonable 
treatment or screening
options are available
The doctor chooses a treatment or
screening option without discussing
harms and benefits with the patient
Informed discussion about the harms
and benefits of available options and 
patient preferences considered
Improved satisfaction and decision
outcomes: more knowledge, less
regret, anxiety and decisional conflict
This may involve a
decision support 
intervention
This may involve 
decision coaching*
Poor understanding, surprise, anger, 
grief, and/or regret if the outcome is
negative or unexpected
This may involve
poor information &
communication
This may involve
ignoring patient 
views and concerns
This may
involve poor 
informed consent
This may involve
clinicians’ training
    in SDM skills 
Figure 1 “Theory of change” underlying the narrative synthesis. *Decision coaching involves preparing and facilitating patient participation in
medical decision-making in a non-directive manner.
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based study were recruited from the general population
[28]. All participants were adults, mostly white and well ed-
ucated. None of the studies explicitly reported the use of
theoretical models or frameworks.
Robustness of the synthesis
The qualitative studies (n = 2, all designs except case
studies) that were rated against CASP had satisfactory
quality ratings (see Table 1) [27,30]. For both studies, the
research design, sampling and data collection procedures
were deemed appropriate. Reflexivity, ethical issues and
analysis could have been improved. The quality of the
case studies (n = 2) was low; these were exclusively based
on documented legal cases [29,31]. Areas of concerns
for both case studies where the absence of dual analysis
involving an independent researcher or triangulation,
the lack of clearly formulated questions and conceptual
framework and lack of information about the data col-
lection and data analysis procedures. Findings should
therefore be interpreted with caution. The quality of the
quasi-experimental study was low, but consistent with
Downs and Black’s average ratings for non-randomized
studies [28]. Given this study was based on a simulated
court case, where lay people were asked to behave ashypothetical jurors, external validity was poor and in-
ternal validity was low with a high risk of selection bias
and other confounders.
Narrative synthesis
The relationships and patterns occurring across the five
included studies were thematically analyzed and synthe-
sized. Given the heterogeneity of the included outcomes,
it was not possible to synthesize the data according to
their outcome measures (se Table 1). The following
themes, closely linked to the study outcomes, emerged:
1) Interfering with patient preferences; 2) Documenting
shared decision-making to meet the standard of care; 3)
Can a decision aid offer medico-legal protection? 4)
Using “defensive medicine” to minimize malpractice liti-
gation Three out of four themes are closely aligned with
the theory of change, which we had developed before
undertaking this analysis and which is represented in
Figure 1. However, theme 4 is one that naturally emerged
from the data analysis, and which we had not anticipated
or identified as prominent.
Theme1: Respecting patient preferences
One might assume that medical malpractice claims are
primarily triggered by an unexpected significant adverse
Figure 2 PRISMA flow diagram.
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view [27] and Um’s case study [31] suggest that other
factors, such as the quality of the doctor-patient rela-
tionship, the consideration and respect for patient pref-
erences, poor communication and patients’ involvement
(or lack of involvement) in the care and decision-making
processes, influence, or may even determine, the initi-
ation of malpractice claims. In a qualitative analysis of
45 plaintiff depositions of settled cases, Beckman et al.
extracted information about the reason(s) motivating the
claim, all information pertaining to the relationship be-
tween the claimant and health provider, and whether a
health professional suggested maloccurrence (i.e. a nega-
tive outcome that is not imputable to the quality of care
provided by the medical team). The authors independently
coded the verbatim transcripts, and identified 15 issues
and their respective frequencies. Their analysis suggested
that problematic patient-provider relationship issues had
occurred in 71% of all depositions (inter-rater reliability of
93.3%). The following four categories emerged: not under-
standing the patient and/or family perspective (13.1%),
dysfunctional delivery of information (26.4%), devaluing
patient and/or family views (28.9%), and patient abandon-
ment (31.6%). Three of these categories (not understandingthe patient and or family perspective, devaluing patient
and/or family views and patient abandonment) are likely to
be associated with the physician’s inability to promote
and support the patient and family’s involvement in
shared decision-making, and consider their concerns
and preferences.
Recurrent in Beckman’s analysis was the clinicians’
tendency to ignore patients’ views, thus infringing on
their autonomy and interfering with their preferences.
Examples of specific issues relating to shared decision-
making included: failure to solicit patient and/or family
opinion (2.6%), discounting a patient and/or family opin-
ion (5.3%), discounting a family’s attempt to advocate
(5.3%), not listening (5.3%), failure to keep a patient and/
or family up to date (5.3%).
Um’s case study of a pregnant woman’s struggle to re-
ceive care and procedures that are aligned with her prefer-
ences [31] illustrates the same theme. The lack of maternal
involvement in deciding about prenatal testing led her to
sue her physician after her newborn baby was diagnosed
with Down’s syndrome. Over the course of the pregnancy,
the pregnant mother, who was aware of family history of
chromosomal abnormality, had repeatedly requested an
amniocentesis. Despite her concerns, and repeated requests
Table 1 Characteristics of included studies
Study Design N Intervention Age Outcomes Conclusion & legal decision Quality scores
Barry et al. [28] Quasi-experimental
(simulated scenarios)
47 A video-
based
decision aid
for PSA
testing
20-70,
M = 50
- Focus group voting
results: whether the
physician met the standard
of care.
- Standard of care met if a
shared decision-making
process is documented in the
patients’ notes: voted by 72%
of mock jurors
10/26
- Standard of care met if
decision aid used prior to
decision-making: voted by
94% of mock jurors
Beckman et al. [27] Qualitative study 45 NA 20-80 - Reason for litigation; - Relationship issues identified
in 71% of the depositions.
7/10
- Specialties of physicians; - 68% of all issues identified
related to the physician’s
failure to communicate clearly
and transparently and to
consider the patient and
family views and preferences
- Type and frequency of
relationship issues;
- Who suggested
maloccurence.
Merenstein [29] Case study 1 NA 53 - Causes and outcome of
the medical malpractice trial
Dr Merenstein’s residency was
found liable for not meeting
the standard of care, despite
having complied with the
principles of shared decision-
making, evidence-based
medicine and the National
guidelines.
6/29
Stapleton et al. [30] Qualitative study
(observation and in
depth interviews)
886 Evidence-
based
leaflets for
pregnancy
Not
known
- Participants’ views on the
use of evidence-based leaf-
lets and its influence on
litigation
Health care providers felt that
ordering more tests and
procedures offered better
protection against litigation
than promoting evidence-
based leaflets and patient
preferences.
7/10
Um [31] Case study 1 NA 33 - Causes and outcome of
the medical malpractice trial
An obstetrician who
discounted his patient’s wish
to undergo amniocentesis
testing was found guilty for
interfering with the patient’s
self-determination, after the
plaintiff gave birth to a baby
diagnosed with Down’s
syndrome.
14/29
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the procedure. The obstetrician was sued on the grounds of
negligence and found liable for interfering with the
“mother’s right to self-determination”, thus interfering with
her preferences [31]. Her views and preferences had clearly
been expressed, but were overruled by the health care pro-
vider. In this particular instance, a lawsuit could have been
avoided if the provider had respected her explicit and in-
formed preferences.
Using data from actual malpractice lawsuits in differ-
ent contexts and clinical areas, both studies demonstrate
that over and above the importance of good communi-
cation, the inability to involve patients in decision-
making and to consider their concerns and preferences
can incite patients to commence litigation. In Beckman’s
study, the authors insist on the impact of “devaluing a pa-
tient’s or family views” on medical malpractice intentions,referring to “particularly risk-laden form of sharing
information”.
While the above analysis indicates that discounting pa-
tients’ views might increase the risk of litigation, one of five
studies included in this review examined the implications
of discussing the pros and cons of PSA testing [29]. In
1999, when advising a 53 year old patient, Dr Merenstein,
reports testifying that he followed the principles of shared
decision-making as well as the US National guidelines for
prostate cancer screening (Guidelines of the American
Academy of Family Physicians, the American Urological
Association and the American Cancer Society). He dis-
cussed the pros and cons of screening for a disease that, if
left undiagnosed, may not be life threatening, and described
the poor accuracy and potential harms of the PSA test. The
patient subsequently declined to have PSA screening. The
discussion and the patient’s decision were documented by
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ician who ordered a PSA test without discussion. This test
led to a diagnosis of prostate cancer. The plaintiff denied
that an informed discussion about the risks and benefits of
the PSA test had occurred. There was testimony from two
physicians, on behalf of the plaintiff, that the standard of
care in Virginia was to not discuss the uncertainties of
testing, but rather to perform the test. Dr Merenstein’s
residency program was found negligent because of the
previous failure to perform a PSA test. Dr Merenstein
and a defense expert testified that Merenstein had never-
theless followed published clinical practice guidelines, had
discussed the harms and uncertainties of the test, and pro-
moted shared decision-making and his patient’s autonomy.
The jury and the plaintiff ’s lawyers did not recognize this
process as being consistent with the standard of care.
While Dr Merenstein was not found negligent, his resi-
dency program was found liable and the case was set-
tled without further appellate review. It is important to
recognize that there are many variables that may have
influenced the jury’s decision.
Theme 2: Documenting shared decision-making to meet the
standard of care
In response to the Merenstein trial, Barry et al. conducted
a simulation study [28] to investigate whether involving
patients in PSA screening decisions would influence a
jury’s verdict, and examine whether the Merenstein out-
come had been atypical. Lay participants were divided into
six focus groups and instructed to behave as hypothetical
jurors in considering two variations of the Merenstein
case. In the first variation, narrated to the first three
groups, the physician’s notes did not mention a discussion
about the risks and benefits of the PSA screening (“no
pros and cons note” scenario). In the second variation,
presented to the remaining three groups, the physician
had clearly documented a discussion about the harms and
benefits of PSA screening, resulting in the patient’s in-
formed decision to decline the test (“pros and cons note”
scenario). All potential jurors were asked to decide
whether the physician had met the standard of care, and if
not, whether any harm had been caused. The majority of
participants (83%) in the first three groups considered that
there was deviation from the standard of care, i.e. negli-
gence, and no informed consent. As one participant com-
mented: “Not documented, not done.”
Further, 61% of the participants in the first three
groups also believed that harm had been caused. Al-
though there is no clear evidence that ordering the PSA
test would have affected the cancer prognosis, the
majority of mock jurors in the first three groups (61%)
believed that ordering the test would have saved the pa-
tient’s life or significantly improved the outcome. In
their words: “Because of the severity of the disease, thedoctor should have done the test as a standard process.
Even if he explained the pros and cons, I don’t think
there should be a question of him not doing the test. He
should do it as a standard process with no discussion.”
This reflects a trend to use tests and invasive proce-
dures, even if the benefits are unclear and some individ-
uals might thus prefer to decline the test when
informed. The participants’ view was reminiscent of the
Merenstein judgment.
However, when presented with the “pros and cons sce-
nario”, 72% of all participants considered that promoting
patient choice and facilitating shared decision-making met
the standard of care, provided the discussion had been doc-
umented in the patient’s record. Contrary to the outcome
of the Merenstein trial, these findings indicate that embed-
ding and documenting shared decision-making in routine
clinical practice could provide a higher degree of medico-
legal protection and lead to better informed consent. How-
ever, this should be interpreted in light of contextual factors
and study limitations. First, the vote for the second scenario
(pros and cons) was not unanimous: 28% believed that the
standard of care had not been met, and 23% felt that harm
had been caused. Although a minority vote, it mirrors the
outcome of the Merenstein case. Second, given the simu-
lated nature of the study, it is difficult to infer whether this
outcome would be representative of similar malpractice re-
sults. However, these findings indicate that shared decision-
making documented in the patient’s record could provide
what King & Moulton call ‘perfected informed consent’
and, in many instances, may prevent litigation on a failure
to inform claim (see Figure 3).
Theme 3: Can a decision aid offer medico-legal protection?
As part of Barry‘s study, and after the initial set of votes,
all participants were shown a video-based patient deci-
sion aid for PSA screening. They were asked to imagine
that the decision aid had been provided to the patient
prior to his informed refusal, and documented in the
notes. The vote was almost unanimous (94%), confirm-
ing that the standard of care would have been met with-
out any harm caused. One participant said: “The tape
tells you as much as you can possibly tell a patient.” And
another commented: “Let me tell you something, after
watching that video, there’s no way that you could not
know what it is, the pros and cons, the risks, the quantity,
the quality of life, the incontinence, impotence…. Hon-
estly that’s even better than the doctor just saying it to
you.” After being shown the decision support interven-
tion, the majority of participants implicitly conceded
that offering a choice and discussing the pros and cons
were justified, and eventually gained understanding of
the harms, benefits and controversies of the test. Al-
though this finding is based on a simulation study, it
suggests that documenting the use of decision support
Figure 3 Liability risk according to patient involvement in decision-making.
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of care, and could reduce the risk of liability.
Theme 4: Using “defensive medicine” to minimize
malpractice litigation
Two out of the five included studies [29,30] highlight that
a number of health professionals believe that promoting
the use of technological interventions offers the best pro-
tection against litigation. In a maternity clinic, Stapleton
and colleagues observed and interviewed clinicians about
their use, opinion and perceived potential impact on litiga-
tion of evidence-based information leaflets. According to
their observations, obstetricians showed a tendency to
minimize, or not mention, the risk of interventions, treat-
ments or screening procedures. Some obstetricians expli-
citly favored ordering tests and treatments and were
not curious to know the views of their patients. They
strongly believed that their own clinical recommenda-
tion offered better medico-legal protection than adopt-
ing an approach based on informing patients and
adopting a shared decision-making approach. This view
was not shared by the midwives who, by and large, pro-
moted the use of the decision support interventions.
Patients in this study reported feeling ‘bullied’ into
undergoing tests and procedures.Discussion
The assertion that involving patients in decision-making
leads to less litigation has not been extensively studied
and cannot yet be confirmed. No empirical research
conducted in clinical settings has assessed the impact of
shared decision-making and related interventions on
medical malpractice litigation. We are thus unable to de-
termine whether or not shared decision-making and re-
lated interventions can reduce malpractice litigation.
However, three out the five studies analyzed here provide
retrospective and simulated data suggesting that not pay-
ing attention to patient preferences, particularly when no
effort has been made to inform and support understand-
ing of possible harms and benefits, may put clinicians at a
higher risk of litigation. However, given the number, het-
erogeneity and quality of included studies, these findings
should be interpreted with caution. Simulated malpractice
scenarios indicate that supporting and documenting
shared decision-making in the patients’ notes, as well as
using decision support interventions to support patients’
deliberation, would meet the standard of care, and as such,
could offer ‘perfected informed consent’ and might reduce
litigation. Nonetheless, two studies also emphasize that
health professionals are still wary of promoting and re-
specting patient preferences. Many continue to believe
that ordering more tests and procedures, irrespective of
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litigation than the promotion of patient’s autonomy and
informed preferences. This is a complex issue, and one
that might discourage clinicians from practicing SDM.
Further, it is worth noting that adopting shared decision-
making without accurately documenting the process, even
when decisions are aligned with the recommendations in
clinical guidelines, would not be recognized from a
medico-legal perspective as dispositive of the issue (see
Figure 3).
Strength and weaknesses of the study
Several limitations need to be considered. First, studies
that met our inclusion criteria were rare and highly het-
erogeneous, two of which were court-based case studies
in different countries. We decided not to restrict the
type of studies included as we were aware of the lack of
data in this area and wanted to have as comprehensive a
perspective as possible. Synthesizing results of such di-
versity can be problematic and unreliable. In order to
limit interpretation biases, we closely followed the guide-
lines provided by the ESRC framework. We also consid-
ered the impact of contextual factors, particularly for the
included case studies. For instance, the Merenstein verdict
[29] was in opposition with the findings of Beckman’s and
Um’s studies [27,31]. These apparently contradictory rul-
ings were cautiously interpreted in light of contextual fac-
tors. The Merenstein case study is a self-reported case
study published in the Journal of the American Medical
Association. Its scientific quality and validity are therefore
limited, as demonstrated by the quality assessment, but met
the inclusion criteria and provided a unique account of
the possible consequences of promoting shared decision-
making in naturalistic settings. We do not know whether
the Merenstein case is an outlier or whether its outcome
may have been typical or representative of similar mal-
practice litigation cases. However, it is important to bear
in mind that despite the impact that the case and self-
reported commentary have had over the past eight years,
it has absolutely no precedential value as case law. Finally,
and in relation to Barry’s study, it is worth noting that, in
medical malpractice, the determination of whether or not
a ‘standard of care’ is met is typically determined by med-
ical experts, and not by lay people, although the jury
would make the final decision. The findings of Barry’s
study thus need to be interpreted carefully. In a real case
of medical malpractice, the jury’s final decision might have
been influenced by the experts’ discussions and opinions
as to whether or not the standard of care had been met,
which was not the case in Barry’s study.
Comparison with other studies
Ample evidence suggests that patients are less likely to
sue their physician when the relationship is satisfactoryand the provider displays person-centered communica-
tion skills [17,32-34]. However, as demonstrated by this
review, no studies have empirically examined the effect
of shared decision-making on lawsuits. This may be due
to methodological challenges. Litigation is a relatively
rare occurrence. A very large sample size and long-term
follow-up would be required to evaluate, in a controlled
setting, the exact impact of shared decision-making on
litigation incidence and costs. Nonetheless, for over two
decades, many have advocated for shared decision-making’s
role in informed consent procedures [21,35-38]. Green, in
1988, urged physicians and patients to engage in collabora-
tions and agreements about the optimal course of care, to
document it in the patient’s chart, and use “questionnaires
that elicit values, preferences and needs” which we now
refer to as decision support interventions [35].
More recently, King and Moulton examined the princi-
ples underpinning informed consent law in the United
States and exposed that existing medical consent proce-
dures (i.e. the physician and patient based standards) are
not aligned with advances in medicine, easy access to in-
formation, growing expectations, and recent policy devel-
opments promoting patient autonomy and involvement in
health care [5]. The authors suggest a revision of informed
consent doctrine, and propose shared decision-making as
a prerequisite and adjunct to the informed consent
process between provider and patient for preference-
sensitive care or situations of clinical equipoise.
This proposition is supported by empirical evidence
on the effectiveness of informed consent procedures
[38-41], suggesting that informed consent is practiced
today through the “ritualistic recitation of risks and ben-
efits” [42], enumerated on a written form with little or
no engagement of the patient and little or no evaluation
of whether the patient understands any of the risks.
There is no bidirectional discourse. Most clinicians feel
that informed consent is the patient signature on a piece
of paper and do not recognize that informed consent is
the process of communication between provider and pa-
tient and that risks, benefits and alternatives are an es-
sential part of that discussion. In a content analysis of
hospital informed consent forms, Bottrell et al. [38]
established that risks were not systematically portrayed
and the majority of consent forms were used as mere
treatment authorizations, regardless of the quality of the
consent process undergone. Patients cannot therefore
appreciate risks and make an informed decision if the
harms, benefits and alternative options are not presented
in a comprehensive and accessible manner and may later
regret having consented to treatments they had very lit-
tle knowledge of. The shortcomings of current consent
procedures could be remedied by promoting shared
decision-making in the clinical encounter and the use of
decision support interventions, thus ensuring that patients
Durand et al. BMC Health Services Research  (2015) 15:167 Page 10 of 11are thoroughly aware of all aspects of the treatment or
screening options available before engaging in a course of
care [38,43-46]. Promoting shared decision-making and
decision support interventions would contribute to en-
sure that patients’ preferences and self-determination
are respected, and patients are fully informed of all pos-
sible outcomes, harms, benefits and alternative health op-
tions. If such process had occurred in the context of Um’s
case study, the lawsuit would have been avoided and the
patient would have received the desired course of care.
However, a sizeable proportion of health professionals
continue to practice defensive medicine and believe in
the virtue of ordering more tests and procedures to
avoid or reduce litigation risks [47-49]. Gattelari at al.
confirmed people’s common tendency to opt for op-
tional tests when they possess poor knowledge of the
harms and benefits of available options [50]. When pre-
sented with hypothetical scenarios and no explanations
of the harms and benefits of PSA screening or mention
of National Guidelines, the majority of participants felt
that the test should have been ordered, and the GP
found liable for the patient’s negative outcomes. Further,
a study of the impact of National guidelines on physi-
cians’ perceptions of medico-legal risks for PSA screen-
ing found that 46% of surveyed GPs still perceived
medico-legal risk if the test was not performed, despite
clear National guidelines [47].
Conclusions
The desirability of patient involvement in medical
decision-making and its role in informed consent proce-
dures have been advocated for decades. Many have as-
sumed that promoting shared decision-making would
reduce preventable litigation. However, there is to date no
clear evidence to confirm that shared decision-making can
indeed reduce medical malpractice litigation. Given the
number, heterogeneity and quality of included studies, the
review provides insufficient evidence to draw firm conclu-
sions. Data from retrospective and simulated studies seem
to indicate that shared decision-making, and the use of
good quality decision support interventions, could offer
some level of medico-legal protection. It also highlights
some clinicians’ reticence to consider that a patient who
has understood the risks and implications of various tests,
treatments or surgical procedures, might be less likely to
sue. Many clinicians believe that their own medical opin-
ion, combined with more tests and procedures, remains
the best protection against litigation, as illustrated by the
jurors’ verdict in the Merenstein judgment.
While most countries are yet to embed shared
decision-making in legal reforms of informed consent,
Washington State passed legislation in 2007 to change the
informed consent law and offer physicians who practice
shared decision-making with a “certified “ decision aid, ahigher degree of protection against a failure to inform law
suit. There are now five states that have promoted shared
decision-making in state law. Massachusetts now requires
that in order to be a medical home or an accountable care
organization, the state must certify the entity, and it must,
in turn, encourage shared decision-making for certain
preferences sensitive conditions in order to qualify.
Shared decision-making, and the use of decision sup-
port interventions, will only offer an effective alternative
to current informed consent procedures if it becomes
embedded in legislative health policy reforms and part of
common law. It constitutes an overwhelming ethical
imperative in the context of preference sensitive care
where the failure to elicit and act on patients’ prefer-
ences is tantamount to operating on the wrong patient
[51]. Nevertheless, more empirical data is needed to de-
termine the impact of shared decision-making on pre-
ventable litigation and potentially overcome clinicians’
reticence and the illusory protection that defensive
medicine seems to provide.
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